Article Information
History
- March 16, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anh N. Do1,2,#,
- Muhammad Ali2,3,
- Jigyasha Timsina2,3,
- Lihua Wang2,3,
- Daniel Western2,3,
- Menghan Liu2,3,
- Jessie Sanford2,3,
- Matitee Rosende-Roca4,
- Merce Boada4,
- Raquel Puerta4,
- Ted Wilson5,
- Agustin Ruiz4,
- Pau Pastor6,
- the Alzheimer’s Disease Neuroimaging Initiative (ADNI)***,
- Tony Wyss-Coray5,
- Carlos Cruchaga2,3,7 and
- Yun Ju Sung1,2,3
- 1Division of Biostatistics, Washington University School of Medicine, St. Louis, MO, USA
- 2NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, MO, USA
- 3Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
- 4Research Center and Memory clinic Fundació ACE. Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain
- 5Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA
- 6Memory Disorders Unit, Department of Neurology, University Hospital Mutua Terrassa, Terrassa, Spain
- 7Hope Center for Neurologic Diseases, Washington University in St. Louis, St. Louis, MO, USA
- ↵#Corresponding author; email: ado{at}wustl.edu
Posted March 16, 2024.
CSF proteomic profiling with amyloid/tau positivity identifies distinctive sex-different alteration of multiple proteins involved in Alzheimer’s disease
